GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » EV-to-EBITDA

China Isotope & Radiation (HKSE:01763) EV-to-EBITDA : 2.14 (As of May. 11, 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, China Isotope & Radiation's enterprise value is HK$2,245 Mil. China Isotope & Radiation's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil. Therefore, China Isotope & Radiation's EV-to-EBITDA for today is 2.14.

The historical rank and industry rank for China Isotope & Radiation's EV-to-EBITDA or its related term are showing as below:

HKSE:01763' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.96   Med: 4.44   Max: 10.46
Current: 2.15

During the past 9 years, the highest EV-to-EBITDA of China Isotope & Radiation was 10.46. The lowest was 1.96. And the median was 4.44.

HKSE:01763's EV-to-EBITDA is ranked better than
92.13% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 16.47 vs HKSE:01763: 2.15

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-11), China Isotope & Radiation's stock price is HK$11.00. China Isotope & Radiation's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.269. Therefore, China Isotope & Radiation's PE Ratio for today is 8.67.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


China Isotope & Radiation EV-to-EBITDA Historical Data

The historical data trend for China Isotope & Radiation's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation EV-to-EBITDA Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only 6.15 8.68 5.53 3.35 4.23

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.53 - 3.35 - 4.23

Competitive Comparison of China Isotope & Radiation's EV-to-EBITDA

For the Medical Devices subindustry, China Isotope & Radiation's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's EV-to-EBITDA falls into.



China Isotope & Radiation EV-to-EBITDA Calculation

China Isotope & Radiation's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=2244.802/1048.474
=2.14

China Isotope & Radiation's current Enterprise Value is HK$2,245 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1,048 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation  (HKSE:01763) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

China Isotope & Radiation's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.00/1.269
=8.67

China Isotope & Radiation's share price for today is HK$11.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.269.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


China Isotope & Radiation EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines